Explore how adverse drug reactions evolve across the pharmacovigilance lifecycle, highlighting post-marketing safety, inspection-sensitive gaps, and structured workflows that ensure regulatory compliance, traceable oversight, and proactive risk management for pharmaceutical teams.
